Skip to contentH
Healthstream Inc
H
HSTMHealthstream Inc Q4 2025 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$79.71M$79.71Mderived+7.4% vs Q4 2024 Net Income$2.54M$2.54Mderived−48.1% vs Q4 2024 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Healthstream Inc · CIK 1095565 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Incomederived$2,405,000−48.7% Operating Cash Flowderived$13,192,000+18.2% Free Cash Flowderived$12,988,000+18.5% Margins · derivedOperating margin3.0%−3.3 pt vs Q4 2024
Net margin3.2%−3.4 pt vs Q4 2024
ended Dec 31, 2025 · filed Feb 27, 2026 · 58 d after period end